← Back to Search

HealthMindr App for Human Immunodeficiency Virus Infection

N/A

Waitlist Available

Led By Patrick Sullivan, DVM PhD

Research Sponsored by Emory University

Eligibility Criteria Checklist

Specific guidelines that determine who can or cannot participate in a clinical trial

Must have

Be between 18 and 65 years old

Timeline

Screening 3 weeks

Treatment Varies

Follow Up 3, 6, 9, and 12 months post-randomization

Awards & highlights

Study Summary

This trial will test a mobile app designed to increase uptake of PrEP, a medication that prevents HIV, among MSM. The app will provide information about PrEP and other HIV prevention methods, as well as provider locators. The trial will compare uptake of PrEP in the intervention arm (with the app) to the control arm (without the app).

Timeline

Screening ~ 3 weeks3 visits

Treatment ~ Varies

Follow Up ~ 3, 6, 9, and 12 months post-randomization

Screening ~ 3 weeks

Treatment ~ Varies

Follow Up ~3, 6, 9, and 12 months post-randomization

This trial's timeline: 3 weeks for screening, Varies for treatment, and 3, 6, 9, and 12 months post-randomization for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.

Primary outcome measures

Change in PrEP Uptake

Trial Design

2Treatment groups

Experimental Treatment

Placebo Group

Group I: HealthMindr AppExperimental Treatment1 Intervention

Participants in the intervention arm will receive access to all HealthMindr app capabilities. The app information will cover the importance of testing, links to HIV prevention resources, resources to locate HIV testing and PrEP services, the Substance Abuse and Mental Health Services Administration (SAMHSA) substance abuse treatment resource locator, and other prevention information specific to their area.

Group II: Control AppPlacebo Group1 Intervention

Participants in the control arm will be directed to download a study app that allows study staff to interact with them.

Treatment

First Studied

Drug Approval Stage

How many patients have taken this drug

HealthMindr App

2020

N/A

~660

Do I qualify?Apply below to find out

Find a Location

Who is running the clinical trial?

Emory UniversityLead Sponsor

1,640 Previous Clinical Trials

2,560,038 Total Patients Enrolled

National Institutes of Health (NIH)NIH

2,701 Previous Clinical Trials

7,506,192 Total Patients Enrolled

National Institute on Drug Abuse (NIDA)NIH

2,470 Previous Clinical Trials

2,619,073 Total Patients Enrolled

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Is this trial open to applicants aged fifty and up?

"This clinical trial's criteria necessitates that patients are between 18 to 34 years old. By comparison, there is a selection of 108 trials oriented towards minors and 352 directed at those over 65."

Answered by AI

Are there still enrolment opportunities available for this trial?

"Clinicaltrials.gov has reported that the recruitment period for this study, which began on January 28th 2020 and was last modified June 27th 2022, is now concluded. However, 486 other trials are still recruiting participants at this time."

Answered by AI

Does my profile match the criteria of this clinical trial?

"This clinical trial seeks 658 cisgender males between 18 and 34 years old who reside in one of the study metropolitan statistical areas, own an Android or Apple device, are capable of comprehending English unaided, have reported anal intercourse with another man during the last six months, and report being HIV negative or untested."

Answered by AI

Recent research and studies

JMIR Research ProtocolsJournal

A Theoretically-based Mobile App to Increase Pre-exposure Prophylaxis Uptake Among Men Who Have Sex with Men: Protocol for a Randomized Controlled Trial

Jones, Jeb, Karen Dominguez, Rob Stephenson, Joanne D Stekler, Amanda D Castel, Leandro A Mena, Samuel M Jenness, Aaron J Siegler, and Patrick S Sullivan. 2020. “A Theoretically-based Mobile App to Increase Pre-exposure Prophylaxis Uptake Among Men Who Have Sex with Men: Protocol for a Randomized Controlled Trial”. JMIR Research Protocols. JMIR Publications Inc.. doi:10.2196/16231.

JMIR Research ProtocolsJournal

A Theoretically-based Mobile App to Increase Pre-exposure Prophylaxis Uptake Among Men Who Have Sex with Men: Protocol for a Randomized Controlled Trial

clinicaltrials.govStudy

HealthMindr App to Increase Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex With Men (MSM)

Patrick S Sullivan 2020. "HealthMindr App to Increase Pre-exposure Prophylaxis (PrEP) Uptake and Retention Among Men Who Have Sex With Men (MSM)". ClinicalTrials.gov. https://clinicaltrials.gov/ct2/show/NCT03763942.